@body
HRT and TRT: Separating Evidence from Marketing
Written by
The WHI scare and the FDA’s testosterone caution both trace back to specific, narrower findings than the headlines suggested. What the timing hypothesis and the TRAVERSE trial actually changed – and where hormone marketing still outruns the data. Read more…
Peptide Therapies May Get Easier to Get. Should You Care?
Written by
The FDA is weighing legal access to BPC-157, TB-500, and other peptides. Easier access is not the same as proven efficacy – here is what the evidence actually says. Read more…
Is It Ever Safe to Use Expired Medication?
Written by
Expiration dates mean different things for different drugs. Here is which ones you can be flexible with and which ones you should never gamble on. Read more…
Why Your Walking Speed Might Be a Brain-Health Signal
Written by
A study of adults 80+ found the fastest walkers had roughly half the cognitive decline risk of the slowest. Here is what that correlation actually means. Read more…
This Month in Longevity Research: Cartilage and Funding
Written by
A microRNA that protects cartilage under load, and a new nonprofit betting on unglamorous basic aging research – this month’s longevity science roundup. Read more…
The Sleep Disorder Women Mistake for Burnout
Written by
Women with sleep apnea report worse symptoms than men despite similar airway obstruction – and those symptoms look a lot like burnout. Read more…
